18 Jun 2026
Climate Tech SPACs Are Back
SPACs are back! At the start of this decade, special purpose acquisition companies — publicly traded firms whose raison d’être is taking startups public through mergers — went from a niche financial vehicle to one of Wall Street’s hottest trends.
10 Jun 2026
Parabilis sets a record with a $670M biotech IPO
Parabilis Medicines, a high-profile startup making medicines for “undruggable” targets, raised $670 million in an initial public offering on Wednesday, a record haul for a venture-backed biotechnology company.
